BREAKING
Viavi Solutions Stock Jumps 5.3% in Broad Rally 2 hours ago Prologis, Inc. Delivers Q1 Upside: EPS Beats by 82.9%, Revenue Up 7% 3 hours ago MaxLinear, Inc. Jumps 5.4% Amid Sector-Wide Selling 4 hours ago Saia, Inc. Jumps 6.2% 4 hours ago Abbott Laboratories Shares Dropping 5.6% 4 hours ago Manhattan Bridge Capital, Inc. (LOAN) Reports Q1 2026 Earnings 4 hours ago Insteel Industries Inc. Q2: Revenue Hits $172.7M, Up 8% Year-Over-Year 4 hours ago Kaiser Aluminum Corporation (KALU) Jumps 6.2% to $146.69 4 hours ago KeyCorp Posts 10% Revenue Jump in Q1, Beats on EPS 4 hours ago Rxo, Inc. Jumps 5.6% in Broad Selloff 5 hours ago Viavi Solutions Stock Jumps 5.3% in Broad Rally 2 hours ago Prologis, Inc. Delivers Q1 Upside: EPS Beats by 82.9%, Revenue Up 7% 3 hours ago MaxLinear, Inc. Jumps 5.4% Amid Sector-Wide Selling 4 hours ago Saia, Inc. Jumps 6.2% 4 hours ago Abbott Laboratories Shares Dropping 5.6% 4 hours ago Manhattan Bridge Capital, Inc. (LOAN) Reports Q1 2026 Earnings 4 hours ago Insteel Industries Inc. Q2: Revenue Hits $172.7M, Up 8% Year-Over-Year 4 hours ago Kaiser Aluminum Corporation (KALU) Jumps 6.2% to $146.69 4 hours ago KeyCorp Posts 10% Revenue Jump in Q1, Beats on EPS 4 hours ago Rxo, Inc. Jumps 5.6% in Broad Selloff 5 hours ago
ADVERTISEMENT
Breaking News

The Charles Schwab Corporation (SCHW) Drops 4.7% to $95.46

Charles Schwab shares tumbled Thursday after Morgan Stanley slashed its price target on the brokerage giant, sending the stock down 5.2% to $95.10. The Capi...

April 16, 2026 2 min read

Charles Schwab shares tumbled Thursday after Morgan Stanley slashed its price target on the brokerage giant, sending the stock down 5.2% to $95.10. The Capi...

SCHW
Price
$95.46
Change
-4.7%
Volume
5.7M

Charles Schwab shares tumbled Thursday after Morgan Stanley slashed its price target on the brokerage giant, sending the stock down 4.7% to $95.46. The Capital Markets firm saw heightened trading activity with 5.7M shares changing hands as investors digested the Wall Street firm’s reduced outlook for the $167.3B company.

Morgan Stanley cut its price target to $135 from $148, representing an 8.8% reduction, while maintaining an Overweight rating on the stock. The downgrade comes as Schwab navigates a shifting landscape for brokerage firms, with the analyst action suggesting a more cautious view on the company’s near-term prospects despite maintaining a positive long-term stance. The new target still implies upside from current levels, but the magnitude of the cut was enough to trigger a sharp selloff in Thursday’s session.

The timing of the analyst action coincides with additional signals around index inclusion and merger acquisition activity in the sector. While Morgan Stanley remains constructive with its Overweight rating, the reduced price target indicates concerns about the pace of growth or potential headwinds facing the brokerage platform. The stock’s decline suggests investors are taking a more defensive posture, preferring to wait for clearer signals before deploying capital.

Thursday’s volume and price action underscore the market’s sensitivity to Wall Street commentary on major financial services names. The single analyst action was enough to drive meaningful selling pressure, indicating that investors are closely watching for any signs of deteriorating fundamentals or competitive pressures in the discount brokerage space. The sharp move lower on analyst commentary alone suggests the stock may have limited near-term catalysts to offset negative sentiment.

What to Watch: Investors should monitor whether additional analysts follow Morgan Stanley’s lead with target reductions, and watch for any company commentary on client activity trends or net new assets. Any clarity on the index inclusion and merger acquisition signals could also provide direction for the stock in coming sessions.

This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.

ADVERTISEMENT